| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Board of Management and Trustees of the British Journal of Anaesthesia [2008]. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Assessment of neuropathic pain
SpR Palliative Medicine
Chronic Pain Team
Seacroft Hospital
York Road
Leeds
LS146UH, UK
Senior Clinical Lecturer in Palliative Medicine
Clinical Teaching and Research Unit
St Gemmas Hospice
Leeds
LS17 6QD, UK
Professor of Palliative Medicine
International Observatory on End of Life Care
Institute for Health Research
Lancaster University
Bowland Tower East
Lancaster
LA1 4YT, UK
Tel: +44 1524 593309 E-mail: m.i.bennett@lancaster.ac.uk
| The first 150 words of the full text of this article appear below. |
Key points
|
Neuropathic pain is defined as pain initiated or caused by a primary lesion or dysfunction of the nervous system.1 It can be a debilitating and difficult condition to treat and is often resistant to simple analgesics, requiring additional analgesic approaches.2 Recent estimates suggest that up to 8% of the general population suffer with pain that is associated with neuropathic features and,
| Classification of pain |
|---|
| Causes of neuropathic pain |
|---|
| Neuropathic pain mechanisms |
|---|
| Clinical assessment |
|---|
Pain assessment
Clinical features of neuropathic pain
Co-morbidities
Psychosocial history
| Examination |
|---|
Bedside tests
| Additional tests and investigations |
|---|
| Screening tools for neuropathic pain |
|---|